TotalMarketCap

Savara

SVRANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$896.833 M

$4.37 -6.33%

Close of 6 Nov 2026

As of 6 Nov 2026, Savara (SVRA) has a market capitalization of $896.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$118.8M

Loss-making

Shares outstanding

205,460,015

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #145HarrowHROW$975.1M
  2. #146MoonLake ImmunotherapeuticsMLTX$919.6M
  3. #147SavaraSVRA$896.8M
  4. #148Jade BiosciencesJBIO$896.1M
  5. #149Pharming GroupPHAR$884.9M

What if Savara were worth as much as…

Open the what-if tool →

Gold $28.2T

$137,432.45

Per share 31,485× higher

Bitcoin $1.53T

$7,436.23

Per share 1,704× higher

Apple $5.02T

$24,412.45

Per share 5,593× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Savara are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.